Clonazepam in the treatment of psychiatric disorders: An update

International Clinical Psychopharmacology

Volumn 21, Issue 3, 2006, Pages 131-142

  Nardi, Antonio E ^a   Perna, Giampaolo ^b  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

Acute mania; Anxiety disorder; Clonazepam; Panic disorder; Social phobia

Indexed keywords

ALPRAZOLAM; BENZODIAZEPINE DERIVATIVE; BROMAZEPAM; CARBAMAZEPINE; CARBON DIOXIDE; CLONAZEPAM; FLUOXETINE; HALOPERIDOL; IMIPRAMINE; LITHIUM; LORAZEPAM; MONOAMINE OXIDASE INHIBITOR; NORADRENALIN UPTAKE INHIBITOR; PAROXETINE; PLACEBO; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRICYCLIC ANTIDEPRESSANT AGENT; VALPROIC ACID; ZUCLOPENTHIXOL;

ANXIETY; ANXIETY DISORDER; ATAXIA; BEHAVIOR THERAPY; CLINICAL STUDY; CLINICAL TRIAL; COGNITIVE THERAPY; COORDINATION DISORDER; DEPRESSION; DISEASE EXACERBATION; DROWSINESS; DRUG DEPENDENCE; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG HALF LIFE; DRUG MECHANISM; DRUG POTENCY; DRUG TOLERANCE; HUMAN; MANIA; MENTAL DISEASE; MONOTHERAPY; PANIC; PRIORITY JOURNAL; QUALITY OF LIFE; REBOUND; REVIEW; SEXUAL DYSFUNCTION; SIDE EFFECT; SLEEP DISORDER; SOCIAL PHOBIA; SOMNOLENCE; TREATMENT DURATION; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT; WITHDRAWAL SYNDROME;

ANTI-ANXIETY AGENTS; ANXIETY DISORDERS; BIPOLAR DISORDER; CLONAZEPAM; HUMANS; META-ANALYSIS;

EID: 33646700975     PISSN: 02681315     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.yic.0000194379.65460.a6     Document Type: Review

References (74)

1. American Psychiatric Association (1998). Practice guidelines for the treatment of patients with panic disorder. http://www.psych.org/psych_pract/ treatg/pg/ pg_panic.cfm [Accessed 28 May 2004].
2. American Psychiatric Association (2002a). Practice guidelines for the treatment of patients with bipolar disorder. http://www.psych.org/psych__pract/ treatg/ pg/bipolar_revisebook_index.cfm [Accessed 28 May 28 2004].
3. American Psychiatric Association (2002b). Treating bipolar disorder. A quick reference guide. http://www.psych.org/psych_pract/treatg/quick_ref_guide/ bipolar_disorder_qrg940df [Accessed 28 May 2004].
4. Beauclair L, Fontaine R, Annable L, Holobow N, Chouinard G (1994). Clonazepam in the treatment of panic disorder: a double-blind, placebo-controlled trial investigating the correlation between clonazepam concentrations in plasma and clinical response. J Clin Psychopharmacol 14:111-118.
5. Bennett JA, Moioffer M, Stanton SP, Dwight M, Keck PE, Jr (1998). A risk-benefit assessment of pharmacological treatments for panic disorder. Drug Saf 18:419-30.
6. Blanco C, Schneier FR, Schmidt A, Blanco-Jerez CR, Marshall RD, Sanchez-Lacay A, et al. (2003). Pharmacological treatment of social anxiety disorder: a meta-analysis. Depress Anxiety 18:29-40.
7. Bonate PL, Kroboth PD, Smith RB, Suarez E, Oo C (2000). Clonazepam and sertraline: absence of drug interaction in a multiple-dose study. J Clin Psychopharmacol 20:19-27.
8. Bottai T, Hue B, Hillaire-Buys D, Barbe A, Alric R, Pouget R, et al. (1995). Clonazepam in acute mania: time-blind evaluation of clinical response and concentrations in plasma. J Affect Disord 36:21-27.
9. Briggs AC, Stretch DD, Brandon S (1993). Subtyping of panic disorder by symptom profile. Br J Psychiatry 163:201-209.
10. Bruce SE, Vasile RG, Goisman RM, Salzman C, Spencer M, Machan JT, et al. (2003). Are benzodiazepines still the medication of choice for patients with panic disorder with or without agoraphobia? Am J Psychiatry 160: 1432-1438.
11. Calkin PA, Kunik ME, Orengo CA, Molinari V, Workman R (1997). Tolerability of clonazepam in demented and non-demented geropsychiatric patients. Int J Geriatr Psychiatry 12:745-749.
12. Clark HM, Berk M, Brook S (1997). A randomized controlled single blind study of the efficacy of clonazepam and lithium in the treatment of acute mania. Hum Psychopharmacol 12:325-328.
13. Connor KM, Davidson JR, Potts NL, Tupler LA, Miner CM, Malik ML, et al. (1998). Discontinuation of clonazepam in the treatment of social phobia. J Clin Psychopharmacol 18:373-378.
14. Crockett BA, Churchill E, Davidson JRT (2004). A double-blind combination study of clonazepam with sertraline in obsessive-compulsive disorder. Ann Clin Psychiatry 16:127-132.
15. Curtin F, Schulz P (2004). Clonazepam and lorazepam in acute mania: a Bayesian meta-analysis. J Affect Disord 78:201-208.
16. Davidson JRT, Ford SM, Smith RD, Potts NLS (1991). Long-term treatment of social phobia with clonazepam. J Clin Psychiatry 52 (Suppl 11):16-20.
17. Davidson JRT (2004). Use of benzodiazepines in social anxiety disorder, generalized anxiety disorder, and posttraumatic stress disorder. J Clin Psychiatry 65 (Suppl 5):29-33.
18. Davidson JR, Potts N, Richichi E, Krishnan R, Ford SM, Smith R, et al. (1993). Treatment of social phobia with clonazepam and placebo. J Clin Psychopharmacol 13:423-428.
19. Davidson JR, Tupler LA, Potts NLS (1994). Treatment of social phobia with benzodiazepines. J Clin Psychiatry 55 (Suppl 6):28-32.
20. Doyle A, Pollack MH (2004). Long-term management of panic disorder. J Clin Psychiatry 65 (Suppl 5):24-28.
21. Expert Consensus Panel for obsessive-compulsive disorder (1997). Treatment of obsessive-compulsive disorder. J Clin Psychiatry 58 (Suppl 4):2-72.
22. Fossey MD, Hamner MB (1994-95). Clonazepam-related sexual dysfunction in male veterans with PTSD. Anxiety 1:233-236.
23. Gelernter CS, Uhde TW, Cimbolic P, Arnkoff DB, Vittone BJ, Tancer ME, et al. (1991). Cognitive-behavioural and pharmacological treatments of social phobia. A controlled study. Arch Gen Psychiatry 48:938-945.
24. Gelpin E, Bonne O, Peri T, Brandes D, Shalev AY (1996). Treatment of recent trauma survivors with benzodiazepines: a prospective study. J Clin Psychiatry 57:390-394.
25. Goddard AW, Brouette T, Almai A, Jetty P, Woods SW, Charney D (2001). Early coadministration of clonazepam with sertraline for panic disorder. Arch Gen Psychiatry 58:681-686.
26. Gorman JM, Kent JM, Sullivan GM, Coplan JD (2000). Neuroanatomical hypothesis of panic disorder, revised. Am J Psychiatry 157:493-505.
27. Gould RA, Buckminster S, Pollack MH, Otto M, Yap L (1997). Cognitive-behavioral and pharmacological treatment for social phobia: A meta-analysis. Clin Psychol Sci Pract 4:291-306.
28. Gouliaev G, Licht RW, Vestergaard P, Merinder L, Lund H, Bjerre L (1996). Treatment of manic episodes: zuclopenthixol and clonazepam versus lithium and clonazepam. Acta Psychiatr Scand 93:119-124.
29. Graae F, Milner J, Rizzotto L, Klein RG (1994). Clonazepam in childhood anxiety disorders. J Am Acad Child Adolesc Psychiatry 33:372-376.
30. Greenblatt DJ, Preskorn SH, Cotreau MM, Horst WD, Harmatz JS (1992). Fluoxetine impairs clearance of alprazolam but not of clonazepam. Clin Pharmacol Ther 52:479-486.
31. Hewlett WA, Vinogradov S, Agras WS (1992). Clomipramine, clonazepam, and clonidine treatment of obsessive-compulsive disorder. J Clin Psychopharmacol 12:420-430.
32. Hidalgo RB, Barnett SD, Davidson JRT (2001). Social anxiety disorder in review: two decades of progress. Int J Neuropharmacol 4:279-298.
33. Hollander E, Kaplan A, Stahl SM (2003). A double-blind, placebo-controlled trial of clonazepam in obsessive-compulsive disorder. World J Biol Psychiatry 4:30-34.
34. Jacobs RJ, Davidson JR, Gupta S, Meyerhoff AS (1997). The effects of clonazepam on quality of life and work productivity in panic disorder. Am J Manag Care 3:1187-1196.
35. Klonopin® (clonazepam) product information (2001). http://www.rocheusa.com/ products/klonopin/pi.pdf [Accessed 28 May 2004].
36. Labbate LA, Pollack MH, Otto MW, Tesar GM, Rosenbaum JF (1994). The relationship of alprazolam and clonazepam dose to steady-state concentration in plasma. J Clin Psychopharmacol 14:274-276.
37. Lerner AG, Gelkopf M, Skladman I, Rudinski D, Nachshon H, Bleich A (2003). Clonazepam treatment of lysergic acid diethylamide-induced hallucinogen persisting perception disorder with anxiety features. Int Clin Psychopharmacol 18:101-105.
38. Londborg PD, Smith WT, Glaudin V, Painter JR (2000). Short-term cotherapy with clonazepam and fluoxetine: anxiety, sleep disturbance and core symptoms of depression. J Affect Disord 61:73-79.
39. Loewenstein RJ, Hornstein N, Farber B (1988). Open trial of clonazepam in the treatment of post-traumatic stress symptoms in MPD. Dissociation 1:3-12.
40. Mavissakalian MR, Pereal JM (2002). Duration of imipramine therapy and relapse in panic disorder with agoraphobia. J Clin Psychopharmacol 22:294-299.
41. Morishita S, Aoki S (1999). Clonazepam in the treatment of prolonged depression. J Affect Disord 53:275-278.
42. Morishita S, Aoki S (2002). Clonazepam augmentation of antidepressants: does it distinguish unipolar from bipolar depression? J Affect Disord 71:217-220.
43. Moroz G (2004). High-potency benzodiazepines: recent clinical results. J Clin Psychiatry 65 (Suppl 5):13-18.
44. Moroz G, Rosenbaum JF (1999). Efficacy, safety, and gradual discontinuation of clonazepam in panic disorder: a placebo-controlled, multicentre study using optimized dosages. J Clin Psychiatry 60:604-612.
45. Nardi AE (2001). [Clonazepam in panic disorder]. J Bras Psiquiatr 50:407-413.
46. Nardi AE, Valenca AM, Zin W, Nascimento I (1999). Carbon dioxide induced panic attacks and short term clonazepam treatment. Preliminary study. Arq Neuropsiquiatr 57:361-365.
47. Nardi AE, Valenca AM, Nascimento I, Mezzasalma MA, Zin WA (2000). Double-blind acute clonazepam versus placebo in carbon dioxide-induced panic attacks. Psychiatry Res 94:179-184.
48. Nardi AE, Valenca AM, Nascimento I, Lopes FL, Mezzasalma MA, Freire RC, et al. (2005). A three-year follow-up study of patients with the respiratory subtype of panic disorder after treatment with clonazepam. Psychiatry Res 137:61-70.
49. Otto MW, Pollack MH, Gould RA, Worthington JJ III, McArdle ET, Rosenbaum JF (2000). A comparison of the efficacy of clonazepam and cognitive-behavioural group therapy for the treatment of social phobia. J Anxiety Disord 14:345-358.
50. Pecknold JC, Swinson RP, Kuch K, Lewis CP (1988). Alprazolam in panic disorder and agoraphobia: results from a multicentre trial. III. Discontinuation effects. Arch Gen Psychiatry 45:429-436.
51. Pigott TA, L'Heureux F, Rubenstein CS (1992). Clonazepam augmentation in OCD patients treated with clomipramine or fluoxetine. In: New Research Program and Abstracts of the 145th Annual Meeting of the American Psychiatric Association. Washington, DC. Abstract NR144: 82.
52. Pollack MH, Simon NM, Worthington JJ, Doyle AL, Peters P, Toshkov F, et al. (2003). Combined paroxetine and clonazepam treatment strategies compared to paroxetine monotherapy for panic disorder. J Psychopharmacol 17:276-282.
53. Rickels K, Schweizer E, Weiss S, Zavodnick S (1993). Maintenance drug treatment for panic disorder. II. Short- and long-term outcome after drug taper. Arch Gen Psychiatry 50:61-68.
54. Rosenbaum JF (2004). The development of clonazepam as a psychotropic: the Massachusetts General Hospital experience. J Clin Psychiatry 65 (Suppl 5):3-6.
55. Rosenbaum JF, Moroz G, Bowden CL (1997). Clonazepam in the treatment of panic disorder with or without agoraphobia: a dose-response study of efficacy, safety, and discontinuance. Clonazepam Panic Disorder Dose-response Study Group. J Clin Psychopharmacol 17:390-400.
56. Seedat S, Stein MB (2004). Double-blind, placebo-controlled assessment of combined clonazepam with paroxetine compared with paroxetine monotherapy for generalized social anxiety disorder. J Clin Psychiatry 65:244-248.
57. Smith WT, Londborg PD, Glaudin V, Painter JR (1998). Short-term augmentation of fluoxetine with clonazepam in the treatment of depression: a double-blind study. Am J Psychiatry 155:1339-1345.
58. Smith WT, Londborg PD, Glaudin V, Painter JR; Summit Research Network (2002). Is extended clonazepam cotherapy of fluoxetine effective for out patients with major depression? J Affect Disord 70:251-259.
59. Stein DJ, Hollander E, Mullen LS, DeCaria CM, Liebowitz MR (1992). Comparison of clomipramine, alprazolam and placebo in the treatment of obsessive-compulsive disorder. Hum Psychopharmacol 7:389-395.
60. Sutherland SM, Davidson JR (1994). Pharmacotherapy for post-traumatic stress disorder. Psychiatr Clin North Am 17:409-423.
61. Sutherland SM, Tupler LA, Colket JT, Davidson JR (1996). A 2-year follow-up of social phobia. Status after a brief medication trial. J Nerv Ment Dis 184:731-738.
62. Svestka J, Ceskova E, Kamenicka V, Buresova A (1995). [Effectiveness of clonazepam in depressive disorders]. Ceska Slov Psychiatr 91: 199-207.
63. Valenca AM, Nardi AE, Nascimento I, Mezzasalma MA, Lopes FL, Zin W (2000). Double-blind clonazepam versus placebo in panic disorder treatment. Arq Neuropsiquiatr 58:1025-1029.
64. Valenca AM, Nardi AE, Nascimento I, Zin WA, Versiani M (2002a). Carbon dioxide test as an additional clinical measure of treatment response in panic disorder. Arq Neuropsiquiatr 60:358-361.
65. Valenca AM, Nardi AE, Nascimento I, Zin WA, Lopes FL, Mezzasalma MA, et al. (2002b). Early carbon dioxide challenge test may predict clinical response in panic disorder. Psychiatry Res 112:269-272.
66. Valenca AM, Nardi AE, Mezzasalma MA, Nascimento I, Zin WA, Lopes FL, et al. (2003). Therapeutic response to benzodiazepine in panic disorder subtypes. Sao Paulo Med J 121:77-80.
67. Van Ameringen M, Allgulander C, Bandelow B, Greist JH, Hollander E, Montgomery SA, et al. (2003). WCA recommendations for the long-term treatment of social phobia. CNS Spectr 8 (Suppl 1):40-52.
68. Versiani M (2000). A review of 19 double-blind placebo-controlled studies in social anxiety disorder (social phobia). World J Biol Psychiatry 1:27-33.
69. Versiani M, Nardi AE, Petribu KL, Figueira I, Marques C, Mendlowicz M (1997). Clonazepam in social phobia. J Bras Psiq 46:103-108.
70. Von Moltke LL, Greenblatt DJ, Court MH, Duan SX, Harmatz JS, Shader RI (1995). Inhibition of alprazolam and desipramine hydroxylation in vitro by paroxetine and fluvoxamine: comparison with other selective serotonin reuptake inhibitor antidepressants. J Clin Psychopharmacol 15:125-131.
71. Winkler D, Willeit M, Wolf R, Stamenkovic M, Tauscher J, Pjrek E, et al. (2003). Clonazepam in the long-term treatment of patients with unipolar depression, bipolar and schizoaffective disorder. Eur Neuropsychopharmacol 13: 129-134.
72. Worthington JJ III, Pollack MH, Otto MW, McLean RY, Moroz G, Rosenbaum JF (1998). Long-term experience with clonazepam in patients with a primary diagnosis of panic disorder. Psychopharmacol Bull 34:199-205.
73. Wulsin LR, Maddock R, Beitman B, Dawaher R, Wells VE (1999). Clonazepam treatment of panic disorder in patients with recurrent chest pain and normal coronary arteries. Int J Psychiatry Med 29:97-105.
74. Yamada K (1999). Algorithm for the treatment of rapid cycling. Psychiatry Clin Neurosci 53 (Suppl):S73-S75.